Heating, ventilation, air conditioning, and refrigeration company Carrier Global (NYSE:CARR) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 3.7% year on year to $5.22 billion. The company’s full-year revenue guidance of $23 billion at the midpoint came in 1.5% above analysts’ estimates. Its non-GAAP profit of $0.65 per share was 11.3% above analysts’ consensus estimates.
Electronic equipment provider Vontier (NYSE:VNT) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 1.9% year on year to $741.1 million. Guidance for next quarter’s revenue was better than expected at $735 million at the midpoint, 1.2% above analysts’ estimates. Its non-GAAP profit of $0.77 per share was 6.4% above analysts’ consensus estimates.
Wondering if the leading Russell 2000 ETF deserves a spot in your portfolio? Be careful -- you'll need inhuman market timing to beat the broader market.
Industrial products distributor Applied Industrial (NYSE:AIT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.8% year on year to $1.17 billion. Its GAAP profit of $2.57 per share was 6.6% above analysts’ consensus estimates.
Consumer packaging solutions provider Graphic Packaging Holding (NYSE:GPK) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 6.2% year on year to $2.12 billion. On the other hand, the company’s full-year revenue guidance of $8.35 billion at the midpoint came in 3.7% below analysts’ estimates. Its non-GAAP profit of $0.51 per share was 11.5% below analysts’ consensus estimates.
Snack food company Utz Brands (NYSE:UTZ) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.6% year on year to $352.1 million. Its non-GAAP profit of $0.16 per share was in line with analysts’ consensus estimates.
Welding and cutting equipment manufacturer ESAB (NYSE:ESAB) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.7% year on year to $678.1 million. Its non-GAAP profit of $1.25 per share was 3.6% above analysts’ consensus estimates.
Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The company’s full-year revenue guidance of $2 billion at the midpoint came in 6.1% below analysts’ estimates. Its GAAP loss of $2.52 per share was 18.6% above analysts’ consensus estimates.
Engineered components manufacturer for critical industries ITT Inc. (NYSE: ITT) beat Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $913 million. Its non-GAAP profit of $1.45 per share was 0.8% above analysts’ consensus estimates.
Medical technology company Becton, Dickinson and Company (NYSE:BDX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 4.5% year on year to $5.27 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $21.85 billion at the midpoint. Its non-GAAP profit of $3.35 per share was 2.1% above analysts’ consensus estimates.
Gas handling company Chart (NYSE:GTLS) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.3% year on year to $1.00 billion. The company’s full-year revenue guidance of $4.75 billion at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $1.86 per share was 1.8% above analysts’ consensus estimates.
